Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls.

Saved in:
Bibliographic Details
Title: Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls.
Authors: Boekhout, A. H.1, Rogiers, A.2, Jozwiak, K.1,3, Boers-Sonderen, M. J.4, van den Eertwegh, A. J.5, Hospers, G. A.6, de Groot, J. W. B.7, Aarts, M. J. B.8, Kapiteijn, E.9, ten Tije, A. J.10, Piersma, D.11, Vreugdenhil, G.12, van der Veldt, A. A.13, Suijkerbuijk, K. P. M.14, Rozeman, E. A.1, Neyns, B.15, Janssen, K. J.16, van de Poll-Franse, L. V.1, Blank, C. U.1
Source: Acta Oncologica. Jan2021, Vol. 60 Issue 1, p69-77. 9p. 4 Charts, 1 Graph.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:0284186X
DOI:10.1080/0284186X.2020.1818823